National Comprehensive Cancer Network

About NCCN

NCCN Guidelines™ and NCCN Compendium™ Updated

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) and NCCN Drugs & Biologics Compendium (NCCN Compendium™) for Acute Myeloid Leukemia.  These NCCN Guidelines™ are currently available as Version 3.2010.

The version change represents the removal of gemtuzumab ogozamicin due to its withdrawal from the U.S. market.

For the complete updated versions of the NCCN Guidelines™ and the NCCN Compendium™ please visit NCCN.org.